- Email: [email protected]
Abstracts
Volume 15 Number 2, Part 1 August, 1986
22. 23.
24.
25. 26.
27.
28. 29. 30.
Topical c l o b e t a s o l - 1 7 - p r o p i o n a t e
nance therapy in chronic hand eczema with clobetasol propionate and flupredniden acetate. Curr Med Res Opin 8:640-644, 1983. Meenan FOC: The treatment of atopic dermatitis with clobetasol propionate. J Ir Med Assoc 70:316, 1977. Clayton R: A double-blind trial of 0.05% clobetasol propionate in the treatment of vitiligo. Br I Dermatol 96:7173, 1977. Bleehen SS: The treatment of vitiligo with topical corticosteroids. Light and electmnmicroscopic studies. Br J Dermatol 94(suppl 12):43-50, 1976. Kumari J: Vitiligo treated with topical clobetasol propionate. Arch Dermatol 120:631-635, 1984. Carboni G, Longhi-Gelati M, Pieffelice V: Clinical observations on two new liquid presentations of clobetasol propionate in seborrhoeic eczema. G Ital Dermatol Venereol 117:5-10, 1982. Hindson TC, Spiro J, Scott LV: Clobetasol propionate ointment reduces inflammation after cryotherapy. Br J Dermatol 112:599-602, 1985. White MI, Main RA: The treatment of HaUopeau's acrodermatitis. Arch Dermatol 115:235-236, 1979. Kruyswijk MRJ: Granuloma annulare and necrobiosis lipoidica. Ned Tijdschr Geneeskd 123:2163-2168, 1979. Weismann K, Secher L, Kobayasi T, et al: Granulomatosis diseiformis-chronica et progressiva (MieseherLeder). Hautarzt 32:538-540, 1981.
255
31. Ellis JP: Actinic retiguloid--squarnous cell carcinoma of lung. Br J Dermatol 103(suppl 18):73-74, 1980. 32. Matsubara M, Tamaki T, Sata M, et al: An unusual form of pemphigus vegetans. Acta Derm Venereol (Stoekh) 61:259-261, 1981. 33. Levene GM: The treatment of pemphigus and pemphigold. Clin Exp Dermatol 7:643-652, 1982. 34. Pye R J, Peachey RDG, Burton JL: Erosive pustular dermatosis of the scalp. Br J Dermatol 100:559-566, I979. 35. Gomez EC, Kaminester L; Frost P: Topical halcinonide and betamethasone valerate effects on plasma cortisol: Acute and subacute usage studies. Arch Dermatol 113:1196-1202, i 977. 36. Comell RC, Stoughton RB: Six month controlled study of effect of desoximetasone and betamethasone 17-valcrate on the pituitary-adrenal axis. Br J Dermatol 105:9195, 1981. 37. Carm!hers JA, August PJ, Staughton RCD: Observations on the systemic effect of topical clobetasol propionate (Dermovate). Br Med J 4:203-204, 1975. 38. Lawlor F, Ramabala K: Iatrogenic Cushing's syndrome--a cautionary tale. Clin Exp Dermatol 9:286-289, 1984. 39. Parish LC, Witkowski JA, Muir JG: Topical corticosteroids. Int J Dermatol 24:435-436, 1985.
ABSTRACTS Anti-lymphocyte antibodies in systemic lupus erythematosus Winfield JB: Clin Rheum Dis 11:523-549, 1985 AntilymphocyteantibodiesOccurnaturally in systemic luPUserythematosus, usually increasingwhen the disease is active. Are the antibodiesimportantin causingsome componentsof the disease, or are they only a secondaryproductof Uttleimportance?No one knows yet. Philip C. Anderson, M.D.
Lupus pregnancy Loekshin MD: Clin Rheum Dis 11:611-632, 1985 As the author notes, patients with lupus erythematosusoften are told that pregnancyis wholly safe, or at least they claim they have been told that. Such advice is not indicated, and the patient's chart should show that they were warned of risk if they choose to become pregnant. Major problems for mother and infant may develop. Cooperationbetweenthe variousspecialistsis importantand each patient must be followed with care. Philip C. Anderson, M.D.
Primary cutaneous cryptococcosis Baes H, Van Cutsem J: Dermatologica 171:357-361, 1985 No surprise; an elderly asthmatic who was on chronic systemic steroids and who handled pigeons developed cutaneous cryptococcoses on the wrist. Ketaconazolecured him. Philip C. Anderson, M.D.
Therapeutic and clinico-pathological factors in the survival of 1,469 patients with primary cutaneous malignant melanoma in clinical Stage I. A multivariate regression analysis Sondergaard K, Schou G: Virehows Arch 408:149-158, 1985 Repetitiously, and reliably, in these oncologicstudies physicians are taught that many factors do not affect survivat in patients with melanoma; these include the margin of resection, diagnosticbiopsy, removal of deep fascia, or age at surgery. Tell your surgeons. The major factor in forecastingan outcome is the thicknessof the tumor. Other lesser but possibly related factors discussed in this article are ulceration, lymphocytic reaction, sex, mitotic rate, and anatomic level. The numberof patients was 1,469, all with Stage I melanoma. Philip C. Anderson, M.D.
Posttherapeutic allergy to benzoyl peroxide in patients with leg ulcers (German text) Bandmann H-J, Agathos M: Hautarzt 36:670-674, 1985 Benzoyl peroxide has a high sensitizationrisk; therefore, it is not recommended for the treatment of leg ulcers. In contrast, it has no adverse effect in the treatment of acne vulgaris. Alfred Hollander, M.D.
22. 23.
24.
25. 26.
27.
28. 29. 30.
Topical c l o b e t a s o l - 1 7 - p r o p i o n a t e
nance therapy in chronic hand eczema with clobetasol propionate and flupredniden acetate. Curr Med Res Opin 8:640-644, 1983. Meenan FOC: The treatment of atopic dermatitis with clobetasol propionate. J Ir Med Assoc 70:316, 1977. Clayton R: A double-blind trial of 0.05% clobetasol propionate in the treatment of vitiligo. Br I Dermatol 96:7173, 1977. Bleehen SS: The treatment of vitiligo with topical corticosteroids. Light and electmnmicroscopic studies. Br J Dermatol 94(suppl 12):43-50, 1976. Kumari J: Vitiligo treated with topical clobetasol propionate. Arch Dermatol 120:631-635, 1984. Carboni G, Longhi-Gelati M, Pieffelice V: Clinical observations on two new liquid presentations of clobetasol propionate in seborrhoeic eczema. G Ital Dermatol Venereol 117:5-10, 1982. Hindson TC, Spiro J, Scott LV: Clobetasol propionate ointment reduces inflammation after cryotherapy. Br J Dermatol 112:599-602, 1985. White MI, Main RA: The treatment of HaUopeau's acrodermatitis. Arch Dermatol 115:235-236, 1979. Kruyswijk MRJ: Granuloma annulare and necrobiosis lipoidica. Ned Tijdschr Geneeskd 123:2163-2168, 1979. Weismann K, Secher L, Kobayasi T, et al: Granulomatosis diseiformis-chronica et progressiva (MieseherLeder). Hautarzt 32:538-540, 1981.
255
31. Ellis JP: Actinic retiguloid--squarnous cell carcinoma of lung. Br J Dermatol 103(suppl 18):73-74, 1980. 32. Matsubara M, Tamaki T, Sata M, et al: An unusual form of pemphigus vegetans. Acta Derm Venereol (Stoekh) 61:259-261, 1981. 33. Levene GM: The treatment of pemphigus and pemphigold. Clin Exp Dermatol 7:643-652, 1982. 34. Pye R J, Peachey RDG, Burton JL: Erosive pustular dermatosis of the scalp. Br J Dermatol 100:559-566, I979. 35. Gomez EC, Kaminester L; Frost P: Topical halcinonide and betamethasone valerate effects on plasma cortisol: Acute and subacute usage studies. Arch Dermatol 113:1196-1202, i 977. 36. Comell RC, Stoughton RB: Six month controlled study of effect of desoximetasone and betamethasone 17-valcrate on the pituitary-adrenal axis. Br J Dermatol 105:9195, 1981. 37. Carm!hers JA, August PJ, Staughton RCD: Observations on the systemic effect of topical clobetasol propionate (Dermovate). Br Med J 4:203-204, 1975. 38. Lawlor F, Ramabala K: Iatrogenic Cushing's syndrome--a cautionary tale. Clin Exp Dermatol 9:286-289, 1984. 39. Parish LC, Witkowski JA, Muir JG: Topical corticosteroids. Int J Dermatol 24:435-436, 1985.
ABSTRACTS Anti-lymphocyte antibodies in systemic lupus erythematosus Winfield JB: Clin Rheum Dis 11:523-549, 1985 AntilymphocyteantibodiesOccurnaturally in systemic luPUserythematosus, usually increasingwhen the disease is active. Are the antibodiesimportantin causingsome componentsof the disease, or are they only a secondaryproductof Uttleimportance?No one knows yet. Philip C. Anderson, M.D.
Lupus pregnancy Loekshin MD: Clin Rheum Dis 11:611-632, 1985 As the author notes, patients with lupus erythematosusoften are told that pregnancyis wholly safe, or at least they claim they have been told that. Such advice is not indicated, and the patient's chart should show that they were warned of risk if they choose to become pregnant. Major problems for mother and infant may develop. Cooperationbetweenthe variousspecialistsis importantand each patient must be followed with care. Philip C. Anderson, M.D.
Primary cutaneous cryptococcosis Baes H, Van Cutsem J: Dermatologica 171:357-361, 1985 No surprise; an elderly asthmatic who was on chronic systemic steroids and who handled pigeons developed cutaneous cryptococcoses on the wrist. Ketaconazolecured him. Philip C. Anderson, M.D.
Therapeutic and clinico-pathological factors in the survival of 1,469 patients with primary cutaneous malignant melanoma in clinical Stage I. A multivariate regression analysis Sondergaard K, Schou G: Virehows Arch 408:149-158, 1985 Repetitiously, and reliably, in these oncologicstudies physicians are taught that many factors do not affect survivat in patients with melanoma; these include the margin of resection, diagnosticbiopsy, removal of deep fascia, or age at surgery. Tell your surgeons. The major factor in forecastingan outcome is the thicknessof the tumor. Other lesser but possibly related factors discussed in this article are ulceration, lymphocytic reaction, sex, mitotic rate, and anatomic level. The numberof patients was 1,469, all with Stage I melanoma. Philip C. Anderson, M.D.
Posttherapeutic allergy to benzoyl peroxide in patients with leg ulcers (German text) Bandmann H-J, Agathos M: Hautarzt 36:670-674, 1985 Benzoyl peroxide has a high sensitizationrisk; therefore, it is not recommended for the treatment of leg ulcers. In contrast, it has no adverse effect in the treatment of acne vulgaris. Alfred Hollander, M.D.